InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+3.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Schade Christian S, 董事长兼首席执行官. Director active across 2 companies, notably Integra Lifesciences Holdings CORP. Cumulatively, 10 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. History available since 14 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Schade Christian S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
6,939 股0Common StockSEC:0000917520-25-000044:0
8,696 股0Common StockSEC:0001628280-24-022923:0
4,486 股0Common StockSEC:0001209191-23-029792:0
32,400 股0Common StockSEC:0001104659-22-084772:0
65,770 股@ US$0.8050.83% mcap46.5% 占其流量Common StockSEC:0001104659-22-069015:0
37,500 股@ US$0.64330.39% mcap21.7% 占其流量Common StockSEC:0001104659-22-062916:0
标准退出：2022年8月16日 (T+90)
1,265 股0Common StockSEC:0001209191-22-029707:0
100,100 股0Common StockSEC:0001104659-22-033393:0
21,644 股@ US$1.740.56% mcap31.8% 占其流量Common StockSEC:0001104659-22-028767:0
530 股0Common StockSEC:0001209191-21-033148:0
10 条申报中的 10 条
About Schade Christian S
Christian S. Schade is a Director and Chairman & CEO at INTEGRA LIFESCIENCES HOLDINGS CORP and Aprea Therapeutics, Inc. His leadership is essential for the strategic direction of the companies.
